
Integral Vision, Inc. develops, manufactures, and markets flat panel display inspection systems for the display manufacturing processes. It primarily inspects micro displays and small flat panel displays. The company's products evaluate operating displays for cosmetic and functional defects, as well as provide electrical testing. Its products include SharpEye systems that provide flat panel display inspection for reflective, emissive, and transmissive display technologies; and detects functional and cosmetic defects in liquid crystal display (LCD) displays, as well as liquid crystal on silicon, OLED, microelectromechanical systems, 3LCD/high temperature poly-silicon, e-paper, and other display technologies. The company's technologies are applied to various consumer products, including a range of hand held devices, e-books, computer monitors, digital still cameras, HDTV, projectors, and video headsets. It sells its products directly in the United States, as well as through sales representatives in Asia and Europe. Integral Vision, Inc. was founded in 1978 and is headquartered in Wixom, Michigan.
Integral Vision, Inc. trades as INVI on OTC. The company is classified in Industrials / Industrial - Machinery and reports in USD.
The current profile places the business in Industrial - Machinery. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $525,000 of revenue and -$3.10M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Integral Vision, Inc. can be compared against peers such as Atlantis Plastics, Inc., BrewBilt Manufacturing Inc., Brightec, Inc., CFOAM Limited, GenusPlus Group Limited, MS Young Adventure Enterprise, Inc..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $103,459, beta of 0.28, and return on equity of +22.7%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
INVI currently shows total debt of $9.63M and beta of 0.28. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.iv-usa.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.